3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Wilms Tumor
3
Rhabdomyosarcoma, Embryonal
3
Rhabdomyosarcoma
3
Rhabdomyosarcoma, Alveolar
2
Stage I Mixed Cell Type Kidney Wilms Tumor
1
Sarcoma, Ewing
1
Sarcoma, Alveolar Soft Part
1
Sarcoma
1
Pleuropulmonary blastoma
1
Histiocytoma, Malignant Fibrous
1
Dermatofibrosarcoma
1
Beckwith-Wiedemann Syndrome
1
Interventions
pembrolizumab
57
Nivolumab
50
Ipilimumab
31
Specimen Handling
23
Magnetic Resonance Spectroscopy
19
Cyclophosphamide
14
Biopsy
11
fludarabine
10
binimetinib
10
Opdualag
10
trametinib
9
relatlimab
9
Radiosurgery
9
CTLA-4 Antigen
9
dabrafenib
8
lifileucel
7
fludarabine phosphate
7
aldesleukin
7
encorafenib
6
Interleukin-2
6
cemiplimab
5
atezolizumab
5
Paclitaxel
5
Blood Specimen Collection
5
X-Rays
4
Taxes
4
Pemetrexed
4
Gemcitabine
4
Cisplatin
4
Carboplatin
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Melanoma
×
Dactinomycin
×
90 days
×
Clear all
No trials found.